Affairs of State

As FDA monitors more international clinical trials, new policies aim to address differences in national approaches to such issues as placebos and protocols.

Related Content:

Applied Clinical Trials-07-01-2001

Letters to the Editor

Conference Reports

Pen-Based Computing